Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.

IF 5.2 1区 医学 Q1 PSYCHIATRY
Addiction Pub Date : 2024-12-01 Epub Date: 2024-09-04 DOI:10.1111/add.16624
Jonathan Livingstone-Banks, Nicola Lindson, Jamie Hartmann-Boyce
{"title":"Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.","authors":"Jonathan Livingstone-Banks, Nicola Lindson, Jamie Hartmann-Boyce","doi":"10.1111/add.16624","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To summarise systematic reviews on tobacco addiction published by the Cochrane Tobacco Addiction Group (CTAG) from 2021 to 2023.</p><p><strong>Methods: </strong>We identified all new and updated Cochrane Reviews published by CTAG between 2021 and 2023. We present key results from these reviews and discuss promising avenues for future research.</p><p><strong>Results: </strong>CTAG published five new reviews and one overview of reviews, and updated eight reviews. Review evidence showed that all main pharmacotherapies (varenicline, cytisine, bupropion and nicotine replacement therapy [NRT], especially when patches are combined with fast acting forms like gum) are effective for smoking cessation, as are nicotine e-cigarettes. Evidence suggested similar magnitude of effects of varenicline, cytisine, and nicotine e-cigarettes; these emerged as the most effective treatments. Evidence also supported behavioural counselling and financial incentives for smoking cessation. Secondary analyses of the Cochrane review of e-cigarettes for smoking cessation showed over half of participants assigned to e-cigarette conditions were still using them at six months or longer, that biomarkers of potential harm significantly reduced in people switching from smoking to vaping or to dual use, and that there was insufficient evidence to draw associations between e-liquid flavours and smoking cessation. Findings on mindfulness-based interventions, interventions delivered by dental and primary care professionals, interventions to prevent weight gain after smoking cessation, and interventions for waterpipe cessation were less certain. Reviews of observational evidence showed that smoking cessation reduced cardiovascular events and mortality in people living with cardiovascular disease, and improved mental health.</p><p><strong>Conclusions: </strong>Nicotine replacement therapy (especially patches combined with fast acting forms), varenicline, cytisine, bupropion, nicotine e-cigarettes, behavioural counselling, and financial incentives are all effective ways to help people quit smoking. Quitting smoking improves mental health and reduces cardiovascular events and mortality in people living with cardiovascular disease.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":"2101-2115"},"PeriodicalIF":5.2000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1111/add.16624","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To summarise systematic reviews on tobacco addiction published by the Cochrane Tobacco Addiction Group (CTAG) from 2021 to 2023.

Methods: We identified all new and updated Cochrane Reviews published by CTAG between 2021 and 2023. We present key results from these reviews and discuss promising avenues for future research.

Results: CTAG published five new reviews and one overview of reviews, and updated eight reviews. Review evidence showed that all main pharmacotherapies (varenicline, cytisine, bupropion and nicotine replacement therapy [NRT], especially when patches are combined with fast acting forms like gum) are effective for smoking cessation, as are nicotine e-cigarettes. Evidence suggested similar magnitude of effects of varenicline, cytisine, and nicotine e-cigarettes; these emerged as the most effective treatments. Evidence also supported behavioural counselling and financial incentives for smoking cessation. Secondary analyses of the Cochrane review of e-cigarettes for smoking cessation showed over half of participants assigned to e-cigarette conditions were still using them at six months or longer, that biomarkers of potential harm significantly reduced in people switching from smoking to vaping or to dual use, and that there was insufficient evidence to draw associations between e-liquid flavours and smoking cessation. Findings on mindfulness-based interventions, interventions delivered by dental and primary care professionals, interventions to prevent weight gain after smoking cessation, and interventions for waterpipe cessation were less certain. Reviews of observational evidence showed that smoking cessation reduced cardiovascular events and mortality in people living with cardiovascular disease, and improved mental health.

Conclusions: Nicotine replacement therapy (especially patches combined with fast acting forms), varenicline, cytisine, bupropion, nicotine e-cigarettes, behavioural counselling, and financial incentives are all effective ways to help people quit smoking. Quitting smoking improves mental health and reduces cardiovascular events and mortality in people living with cardiovascular disease.

对抗烟瘾干预措施的效果:Cochrane对2021年至2023年综述的更新。
目的:总结 Cochrane 烟草成瘾小组(CTAG)在 2021 年至 2023 年间发表的有关烟草成瘾的系统综述:我们确定了CTAG在2021年至2023年期间发表的所有新的和更新的Cochrane综述。我们介绍了这些综述的主要结果,并讨论了未来研究的前景:CTAG发表了5篇新综述和1篇综述,并更新了8篇综述。综述证据显示,所有主要药物疗法(伐尼克兰、胞二磷胆碱、安非他明和尼古丁替代疗法,特别是当贴片与口香糖等速效形式相结合时)都能有效戒烟,尼古丁电子烟也是如此。有证据表明,伐尼克兰、胞二磷胆碱和尼古丁电子烟的效果相似;这些都是最有效的治疗方法。证据还支持行为咨询和经济激励戒烟。Cochrane 对电子烟戒烟综述的二次分析表明,超过一半被分配到电子烟条件下的参与者在六个月或更长时间内仍在使用电子烟,从吸烟转为吸食电子烟或双重使用电子烟的人群中,潜在危害的生物标志物显著减少,并且没有足够的证据表明电子烟液口味与戒烟之间存在关联。关于正念干预、牙科和初级保健专业人员提供的干预、防止戒烟后体重增加的干预以及水烟戒烟干预的研究结果不太确定。观察性证据回顾显示,戒烟可减少心血管疾病患者的心血管事件和死亡率,并改善心理健康:结论:尼古丁替代疗法(尤其是结合快速起效剂型的贴片)、伐尼克兰、胞二磷胆碱、安非他明、尼古丁电子烟、行为咨询和经济激励都是帮助人们戒烟的有效方法。戒烟可以改善心血管疾病患者的心理健康,减少心血管事件的发生,降低死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Addiction
Addiction 医学-精神病学
CiteScore
10.80
自引率
6.70%
发文量
319
审稿时长
3 months
期刊介绍: Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信